<DOC>
	<DOCNO>NCT03090334</DOCNO>
	<brief_summary>This multicenter , prospective , open-label , randomized trial . Patients severe abdominal condition develop severe sepsis septic shock receive broad spectrum antibiotic antifungal treatment randomize ( 1:1 ) : 1. discontinue antifungal treatment base negative ( &lt; 80 pg/ml ) result 1,3 beta-d-glucan perform day 0,3,6 10 2. continue antifungal treatment accord attend physician 's decision .</brief_summary>
	<brief_title>A B-D-Glucan Driven Antifungal Stewardship Approach Invasive Candidiasis</brief_title>
	<detailed_description>Primary objective : Our objective establish whether strategy base beta-d-glucan ( BG ) assessment could achieve reduce antifungal consumption patient severe abdominal condition develop severe sepsis septic shock without impact outcome Secondary objective ) Assess accuracy BG diagnosis invasive candidiasis ( IC ) critically ill patient severe abdominal condition develop severe sepsis septic shock . ii ) Describe change time BG value accord colonization status , infection none aforementioned event . Material Methods Study design : multicenter , open label , randomize trial Population : patient severe abdominal condition develop severe sepsis septic shock . 1 . Inclusion Criteria : 1. adult ( ≥ 18 year ) patient ; 2. sign inform consent surgical procedure ; 3. severe sepsis septic shock ; 4. least one follow condition : ) post-operative peritonitis , ii ) recurrent gastrointestinal perforation , iii ) post-operative hepatobiliary and/or pancreatic disorder include necrotizing pancreatitis , iv ) post-operative intra-abdominal abscess , v ) anastomotic leak . 2 . Exclusion criterion a. diagnosis candidiasis enrollment b. exposure past 30 day antifungal treatment diagnosis invasive fungal infection ; c. pregnancy lactation ; d. history allergy antifungal drug ; e. major immunosuppression condition include : i. neutropenia ( &lt; 0.5 × 109 neutrophils/L [ &lt; 500 neutrophils/mm3 ] &gt; 10 day ) , ii . receipt allogeneic stem cell transplant solid organ transplantation , iii . inherit severe immunodeficiency ( chronic granulomatous disease severe combine immunodeficiency ) , iv . HIV infection lymphocyte T CD4+ cell count &lt; 200/mmc . f. patient poor prognosis unable sign inform consent . Procedures Pre-randomization procedure At time patient enrollment ( within 24 h onset severe sepsis/septic shock ) , standardize diagnostic work-up must perform include least : ) two set blood culture ; ii ) 5 surveillance culture ( rectal swab , urine culture , pharyngeal swab , axillary swab , groin swab ) . iii ) case re-intervention percutaneous drainage : Gram stain culture intra-abdominal sample ; iv ) serum BG determination . Antibiotic antifungal empirical therapy start immediately collection microbiological sample accord predefined standard care ( see appendix 1 ) . Once complete procedure patient proceed randomization . Randomization Patient eligible study begin antifungal therapy randomize 1:1 receive ( Group A ) BG drive de-escalation strategy ( Group B ) course antifungal treatment base care provider 's decision . In group , culture yield invasive candidiasis ( see ) patient manage accord guideline exclude per-protocol analysis . In group , BG determination repeat day +3 , +6 +10 start antifungal therapy . Randomization carry provide close envelope participate center immediately study onset .</detailed_description>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis , Invasive</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Antifungal Agents</mesh_term>
	<mesh_term>Miconazole</mesh_term>
	<criteria>a. adult ( ≥ 18 year ) patient ; b. sign informed consent surgical procedure ; c. severe sepsis septic shock ; d. least one follow condition : ) postoperative peritonitis , ii ) recurrent gastrointestinal perforation , iii ) postoperative hepatobiliary and/or pancreatic disorder include necrotizing pancreatitis , iv ) postoperative intraabdominal abscess , v ) anastomotic leak . a. diagnosis candidiasis enrollment b. exposure past 30 day antifungal treatment diagnosis invasive fungal infection ; c. pregnancy lactation ; d. history allergy antifungal drug ; e. major immunosuppression condition include : i. neutropenia ( &lt; 0.5 × 109 neutrophils/L [ &lt; 500 neutrophils/mm3 ] &gt; 10 day ) , ii . receipt allogeneic stem cell transplant solid organ transplantation , iii . inherit severe immunodeficiency ( chronic granulomatous disease severe combine immunodeficiency ) , iv . HIV infection lymphocyte T CD4+ cell count &lt; 200/mmc . f. patient poor prognosis unable sign inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>beta-d-glucan</keyword>
	<keyword>abdominal candidiasis</keyword>
</DOC>